Karen Liu
Ph D in Immunology from Harvard University
Master of Medical Sciences degree from Harvard Medical School
Bachelor of Sciences degree from Cornell University
EMBA degree from CKGSB – Chungkong Graduate School of Business in China

Dr. Karen Liu has been active in China healthcare venture investment since 2005. She is a founding partner of 3E Bioventures Capital, a healthcare focused venture investment firm which invests in new drugs and innovative device and diagnostics.  Prior to 3E, Dr. Karen Liu was a partner of Kaiwu Capital and Managing Director at CRCI Capital, always covering healthcare investing.  

Dr. Karen Liu received her Ph.D in Immunology from Harvard University, Master of Medical Sciences degree from Harvard University, and Bachelor of Sciences degree from Cornell University. She also received an EMBA degree from CKGSB – Chungkong Graduate School of Business in China.